A Plus Biotechnology Co., Ltd.

6918 · TW · Healthcare / Medical Devices

74.20TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close74.20

Open74.20

Day Range74.00 – 74.20

52-Week Range68.30 – 87.53

Volume12.02K

Market Cap2.51B

P/E (TTM)12.98

Forward P/E0.00

EPS5.67

Dividend Yield6.79%

Beta0.08

50-Day Avg74.12

200-Day Avg77.50

About

A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOXiang-Wei Luo
HeadquartersNo.21, Qiaohe Rd, New Taipei City, Taiwan, 235, Taiwan
Websitehttps://www.aplusbio.com

Leadership

Xiang-Wei LuoGM & Director
Pei Jun KeAccounting Supervisor

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	541.85M	615.48M	675.05M	769.59M	835.89M
Growth (%)	-	+13.59%	+9.68%	+14.01%	+8.61%
Cost of Revenue	195.46M	243.94M	214.37M	234.81M	262.43M
Gross Profit	346.39M	371.53M	460.67M	534.78M	573.46M
Gross Margin	63.93%	60.37%	68.24%	69.49%	68.60%
Operating Expense	300.24M	304.93M	292.97M	352.50M	364.70M
Operating Income	46.15M	66.60M	167.71M	182.28M	208.76M
Operating Margin	8.52%	10.82%	24.84%	23.69%	24.97%
EBITDA	-	95.63M	32.12M	216.44M	245.56M
EBITDA Margin	-	15.54%	4.76%	28.12%	29.38%
Net Income	32.94M	45.70M	-11.30M	151.06M	169.38M
Net Income Margin	6.08%	7.43%	-1.67%	19.63%	20.26%
R&D	63.08M	77.00M	59.54M	53.34M	46.64M
R&D as % of Total Revenue	11.64%	12.51%	8.82%	6.93%	5.58%
Interest Expense	2.20M	2.66M	2.71M	2.19M	2.17M
Interest Expense % of Total Revenue	0.41%	0.43%	0.40%	0.28%	0.26%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.21B	1.17B	1.07B	1.18B	1.55B
Total Liabilities	361.91M	296.71M	243.38M	258.27M	284.45M
Total Equity	843.93M	877.80M	827.94M	919.04M	1.26B
Cash	305.09M	237.69M	319.07M	360.97M	604.35M

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	52.95M	60.64M	159.10M	160.96M	158.91M
Capital Expenditure	224.91M	36.77M	9.80M	9.13M	13.63M
Free Cash Flow	-171.96M	23.88M	149.30M	151.82M	145.28M
Dividends Paid	14.32M	15.24M	21.13M	81.49M	121.88M
FCF to OCF	-324.75%	39.37%	93.84%	94.32%	91.42%
Dividend Paid to FCF	-8.33%	63.81%	14.15%	53.68%	83.89%

Key Statistics & Ratios

Market Cap2.51B

Enterprise Value2.25B

Trailing P/E12.98

Forward P/E0.00

Price / Sales2.82

Price / Book2.13

EPS5.67

Book Value35.21

Revenue (TTM)887.93M

Gross Profit (TTM)592.91M

EBITDA230.37M

Profit Margin20.92%

Operating Margin25.22%

Return on Equity15.50%

Return on Assets8.87%

Shares Outstanding34.07M

Shares Float21.30M

Beta0.08

Dividend Yield6.79%

Dividend Rate5.00

Payout Ratio88.21%

Dividends

20261×

5.00Mar 27, 2026

20251×

4.00Apr 18, 2025

20241×

2.73Jul 15, 2024

20231×

0.70Aug 2, 2023